Search for Clinical Trial Results

Sponsored By

Myotonic Dystrophy Type 1 - 22 Studies Found

Status Study
Recruiting Study Name: PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
Condition: Myotonic Dystrophy Type 1
Date: 2016-03-22
Active, not recruiting Study Name: Observational Prolonged Trial in Myotonic Dystrophy Type 1
Condition: Myotonic Dystrophy Type 1
Date: 2014-04-11
Interventions: Behavioral: Behavioural change intervention The intervention is cognitive behaviour therapy (CBT). The C
Active, not recruiting Study Name: Multicenter Observational Study of Myotonic Dystrophy Type 1
Condition: Myotonic Dystrophy Type 1
Date: 2014-12-02
Completed Study Name: A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
Condition: Myotonic Dystrophy Type 1
Date: 2014-12-04
Interventions:
  • Drug: IONIS-DMPKRx Drug

Completed Study Name: Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
Condition: Myotonic Dystrophy Type 1
Date: 2007-12-18
Interventions:
  • Drug: rhIGF-I/rhIGFBP-3 1.0 mg
Completed Study Name: Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy
Condition: Myotonic Dystrophy Type 1
Date: 2013-12-04
Completed Study Name: Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1
Condition: Myotonic Dystrophy
Date: 2011-07-20
Interventions:
  • Drug: Mexiletine 150 mg/kg Mex
Recruiting Study Name: Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy
Condition:
  • Myotonic Dystrophy 1
  • Steinert Disease

Date: 2016-08-12
Interventions: Device: Non Invasive Ventilation. Non Invasive Mechanical Ventilation through oronasal mask. Mode: Bilev
Completed Study Name: Methylphenidate in Myotonic Dystrophy Type 1
Condition: Dystrophia Myotonica 1
Date: 2011-06-01
Interventions:
  • Drug: Methylphenidate One Tabl
Recruiting Study Name: Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Condition: